ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare · Biotechnology
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2024
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 107.61M | $32.37B | +7 | −3 |
| Q1 2026 | 161 | -2 | 108.78M | $35.89B | +4 | −7 |
| Q4 2025 | 162 | -2 | 118.83M | $47.26B | +1 | −2 |
| Q3 2025 | 24 | +1 | 85.59M | $39.02B | +2 | −2 |
| Q2 2025 | 21 | -1 | 76.99M | $25.10B | — | −1 |
| Q1 2025 | 19 | +2 | 40.24M | $10.86B | +3 | −1 |
| Q4 2024 | 17 | 0 | 41.95M | $9.87B | — | — |
| Q3 2024 | 16 | +1 | 39.28M | $10.80B | +2 | −1 |
| Q2 2024 | 15 | — | 40.30M | $9.79B | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 14.97M | — | $3.64B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 6.21M | — | $1.51B | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 6.03M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 6.03M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 6.03M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 6.03M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 14 | Dodge & Cox ✦ | 3.78M | — | $918.58M | 0.6% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 3.49M | — | $847.59M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 3.49M | — | $847.59M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Norges Bank ✦ (passif) | 2.30M | — | $558.12M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passif) | 2.08M | — | $504.60M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passif) | 2.08M | — | $504.60M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 367.29K | — | $89.25M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 367.29K | — | $89.25M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 279.40K | — | $67.89M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 279.40K | — | $67.89M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 271.62K | — | $65.86M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 271.62K | — | $65.86M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 271.62K | — | $65.86M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 271.62K | — | $65.86M | 0.1% | n/c | 1 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 254.00K | — | $61.72M | 0.1% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 138.50K | — | $33.66M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 102.92K | — | $25.01M | 0.1% | n/c | 1 | SEC ↗ |
| 31 | Arrowstreet Capital ✦ | 14.97K | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Gotham Asset Management ✦ | 13.24K | — | $3.22M | 0.0% | n/c | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 1 détenteurs, 4.30K actions, $1,422 déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.